Cassie Jung, Chief Operating Officer at Aquestive Therapeutics, Inc. (AQST), sold 44 shares at $4.87 ($214) on 2024-11-26, disclosed to the SEC on 2024-11-27.
Open-market sale of $214 AQST by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AQST | SELL | 2025-09-08 | $311K | — | Filing → |